-
Company Profile
Versa Networks Inc – Company Profile
Versa Networks Inc (Versa) is a software-defined networking vendor that provides an end-to-end solution to simplify and secure the WAN/branch office network. The company’s Cloud IP Platform provides a broad set of capabilities to build secure enterprise networks and managed service offerings such as Versa SASE, Versa Director, Versa Analytics and Versa Controller. Its products for enterprise include SD-Branch, Secure SD-WAN, and SD-Security. The company’s products for service providers include Managed SD-Branch, Managed Secure SD-WAN, Managed SD-Security, and Managed SD-Router....
Add to Basket -
Sector Analysis
Cybersecurity Market Size, Share & Trends Analysis Report by Type (Enterprise, Consumer), Product (Security Consulting, Managed Service Providers, Identity & Access Management), Vertical, Enterprise Size, Region, and Segment Forecasts, 2022-2026
Cybersecurity Market Report Overview The cybersecurity market size will be valued at $261.01 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.7% over the forecast period. The frequency, complexity, and severity of cyber-attacks have increased, as threat actors continually adapt their strategies. Consequently, it is essential to employ sophisticated cybersecurity measures that can efficiently identify and counteract these threats. Consequently, the evolving security threats coupled with rising threat of targeted cyberattacks are...
-
Product Insights
Interventional Radiology Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Interventional Radiology which generates high quality image of tumour by performing simultaneous motion estimation and motion-compensated image reconstruction for cancer patients undergoing radiation therapy. The report provides comprehensive information about the Interventional Radiology Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.